| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 37,184,000 | 33,248,000 | 25,346,000 | 30,582,000 | | Cost of Revenue | 2,840,000 | 2,848,000 | 20,271,000 | (11,495,000) | | | Gross Profit | 34,344,000 | 30,400,000 | 5,075,000 | 42,077,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,237,000 | 12,492,000 | 22,694,000 | 14,631,000 | | Non Recurring | 663,000 | 735,000 | 1,787,000 | 8,000 | | Others | 13,068,000 | 9,915,000 | 22,597,000 | 10,698,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,376,000 | 7,258,000 | (42,003,000) | 16,740,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,376,000 | 7,258,000 | (42,003,000) | 16,740,000 | | Interest Expense | 3,948,000 | 4,863,000 | (9,613,000) | 23,900,000 | | Income Before Tax | 5,428,000 | 2,395,000 | (32,390,000) | (7,160,000) | | Income Tax Expense | 957,000 | 785,000 | (10,975,000) | (3,417,000) | | Minority Interest | 34,000 | 16,000 | 309,000 | 95,000 | | | | Net Income From Continuing Ops | 4,505,000 | 1,626,000 | (21,106,000) | (3,648,000) | | | Non-recurring Events | | Discontinued Operations | (226,000) | (33,000) | 3,843,000 | 833,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,279,000 | 1,593,000 | (17,263,000) | (2,815,000) | | Preferred Stock And Other Adjustments | 2,559,000 | (2,559,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $6,838,000 | ($966,000) | ($17,263,000) | ($2,815,000) |
|
0.17% Nasdaq 
Income Statement
